Curocell (KOSDAQ:A372320) - Stock Price, News & Analysis

A372320 Stock Overview

Develops CAR-T cell therapy for the treatment of cancer. More details

A372320 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shareholders have been diluted in the past year

Curocell Inc. Competitors

ToolGen

KOSDAQ:A199800

₩348.2b

D&D Pharmatech

KOSDAQ:A347850

₩348.4b

SillaJen

KOSDAQ:A215600

₩357.2b

Genomictree

KOSDAQ:A228760

₩360.9b

Price History & Performance

Summary of all time highs, changes and price drops for Curocell
Historical stock prices
Current Share Price	₩24,200.00
52 Week High	₩43,000.00
52 Week Low	₩23,050.00
Beta	0
11 Month Change	-19.06%
3 Month Change	-24.02%
1 Year Change	-23.90%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	11.52%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	A372320	KR Biotechs	KR Market
7D	-5.8%	-8.1%	2.9%
1Y	-23.9%	18.1%	-2.8%

Return vs Industry: A372320 underperformed the KR Biotechs industry which returned 18.1% over the past year.

Return vs Market: A372320 underperformed the KR Market which returned -2.8% over the past year.

Price Volatility

Is A372320's price volatile compared to industry and market?
A372320 volatility
A372320 Average Weekly Movement	5.1%
Biotechs Industry Average Movement	8.1%
Market Average Movement	5.6%
10% most volatile stocks in KR Market	11.6%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A372320 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A372320's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2016	n/a	n/a	www.curocellbtx.com

Curocell Inc. develops CAR-T cell therapy for the treatment of cancer. It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma. The company was incorporated in 2016 and is based in Daejeon, South Korea.

Curocell Inc. Fundamentals Summary

How do Curocell's earnings and revenue compare to its market cap?
A372320 fundamental statistics
Market cap	₩340.28b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A372320 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A372320 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A372320 perform over the long term?

See historical performance and comparison